Jounce Therapeutics

Jounce Therapeutics is dedicated to transforming the treatment of cancer

Jounce is discovering and developing novel cancer immunotherapies designed to mobilize the immune system to seek out and attack cancerous cells and tumors. Jounce's proprietary product engine has the potential to discover novel biological insights to drive the development of game-changing immunotherapy treatments with highly durable responses, extending and improving patients' quality of life.

Jounce News


Jounce Therapeutics Appoints Richard Murray, Ph.D., to Chief Executive Officer

Read More > >


Dr. James Allison of MD Anderson Cancer Center Awarded 2014 Szent-Györgyi Prize for Progress in Cancer Research

Read More > >